Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Catch-up Vaccination”

17 trials

Showing 17 of 17 results

Not applicableEnded earlyNCT03328013
What this trial is testing

Impact of HPV Vaccination to Catch up in the Emergence of Lesions of the Cervix

Who this might be right for
HPV VaccinationPap SmearCervical Cancer+1 more
University Hospital, Brest 191
Not applicableEnded earlyNCT05462249
What this trial is testing

Impact of Catch-up HPV Vaccination

Who this might be right for
HPVHPV VaccinationVaccine Preventable Disease+2 more
University Hospital, Brest 354
Large-scale testing (Phase 3)Study completedNCT00452452
What this trial is testing

Study Evaluating 13-valent Pneumococcal Conjugate Vaccine Catch-Up Regimens in Older Infants and Children

Who this might be right for
Pneumococcal Infections
Wyeth is now a wholly owned subsidiary of Pfizer 355
Large-scale testing (Phase 3)Active Not RecruitingNCT06838000
What this trial is testing

Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, and Adolescents

Who this might be right for
Pneumococcal Infections
Sanofi Pasteur, a Sanofi Company 1,268
Large-scale testing (Phase 3)Study completedNCT00345358
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 600
Large-scale testing (Phase 3)Study completedNCT00985465
What this trial is testing

Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 218
Post-approval studies (Phase 4)Study completedNCT01193582
What this trial is testing

Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria

Who this might be right for
Pneumococcal Infections
Pfizer 505
Large-scale testing (Phase 3)Study completedNCT00950833
What this trial is testing

Long-term Follow-up Study of Children Previously Primed With GSK Pneumococcal Vaccine (GSK1024850A) and of Unprimed Children

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 466
Large-scale testing (Phase 3)Study completedNCT01153893
What this trial is testing

Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Nigeria

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 105
Large-scale testing (Phase 3)Study completedNCT01175083
What this trial is testing

Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850A

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 300
Large-scale testing (Phase 3)Study completedNCT03885934
What this trial is testing

Safety and Immunogenicity of Catch-up Vaccination Regimens of V114 (V114-024)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 606
Not applicableStudy completedNCT05085717
What this trial is testing

Prevention, Access to Rights, Catch-up Vaccination, Treatment of Conditions During Pregnancy and for Children

Who this might be right for
HIV Infection
Raincy Montfermeil Hospital Group 1,347
Large-scale testing (Phase 3)Study completedNCT01139021
What this trial is testing

One Year Antibody Persistence After a Fourth Dose Boost or Two Catch-Up Doses of Novartis Meningococcal B Recombinant Vaccine Administered Starting From 12 Months of Age and Response to a Third Dose Boost or Two Catch-Up Doses Starting at 24 Months of Age

Who this might be right for
Meningococcal Disease
Novartis Vaccines 508
Not applicableStudy completedNCT05236270
What this trial is testing

CATCH-UP Vaccines: Engaged Approaches to Testing in Community/Healthcare Settings for the Underserved (COVID-19)

Who this might be right for
COVID-19Vaccine Refusal
University of Oklahoma 312
Testing effectiveness (Phase 2)Study completedNCT00513409
What this trial is testing

Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 163
Large-scale testing (Phase 3)Study completedNCT01030822
What this trial is testing

Booster and Catch-up Vaccination With Vaccine GSK1024850A

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 282
Large-scale testing (Phase 3)Study completedNCT00847145
What this trial is testing

Extension Study of V72P13 to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered as a Booster or as a Two-dose Catch-up to Healthy Toddlers

Who this might be right for
Meningococcal Disease
Novartis Vaccines 2,249

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation